Successful management of a lung cancer patient harbouring both EGFR mutation and EML4-ALK fusion gene with disseminated intravascular coagulation

Lung cancer patients harbouring driver oncogene alterations are markedly responsive to molecular target agents, such as epidermal growth factor receptor (EGFR), tyrosine kinase inhibitor (TKI), and echinoderm microtubule-associated protein like 4 – anaplastic lymphoma kinase (EML4-ALK)-TKI. We encou...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Respir Med Case Rep
Asıl Yazarlar: Fujita, Kohei, Naka, Megumi, Ito, Takanori, Kanai, Osamu, Maekawa, Koichi, Nakatani, Koichi, Mio, Tadashi
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elsevier 2021
Konular:
Case Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8024693/
https://ncbi.nlm.nih.gov/pubmed/33854939
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2021.101393
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller